Chemed Corp
Change company Symbol lookup
Select an option...
CHE Chemed Corp
ASTA WorldFlix Inc
$NQDM15LMCADN Nasdaq Developed Markets Telecommuni
BFZ BlackRock California Municipal Income Trust
CAR Avis Budget Group Inc
GIS General Mills Inc
VLN Valens Semiconductor Ltd
CIF MFS? Intermediate High Income Fund
LVOXW LiveVox Holdings Inc *W EXP 06/18/2026
SASR Sandy Spring Bancorp Inc
Go

Health Care : Health Care Providers & Services | Mid Cap Blend
Company profile

Chemed Corporation purchases, operates, and divests subsidiaries engaged in diverse business activities. The Company operates through two segments: the VITAS segment and Roto-Rooter segment. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. The Company's VITAS business is operated in the state of Florida. Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. Its services are provided through a network of company-owned branches, independent contractors, and franchisees. The Company's subsidiaries include Chemed RT, Inc., Comfort Care Holdings Co., Comfort Care Holdings Co. and others.

Closing Price
$430.12
Day's Change
12.45 (2.98%)
Bid
--
Ask
--
B/A Size
--
Day's High
431.43
Day's Low
417.61
Volume
(Light)
Volume:
94,641

10-day average volume:
118,739
94,641

Ocugen Inc. Stock Underperforms Wednesday When Compared To Competitors

5:13 pm ET September 22, 2021 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Ocugen Inc. (OCGN) dropped 0.66% to $7.50 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.95% to 4,395.64 and the Dow Jones Industrial Average rising 1.00% to 34,258.32. Ocugen Inc. closed $11.27 short of its 52-week high ($18.77), which the company achieved on February 8th.

The stock underperformed when compared to some of its competitors Wednesday, as Adverum Biotechnologies Inc. (ADVM) remained unchanged, Ocular Therapeutix Inc. (OCUL) rose 1.83% to $10.58, and Kodiak Sciences Inc. (KOD) rose 0.67% to $102.70. Trading volume (5.7 M) remained 7.8 million below its 50-day average volume of 13.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled September 22, 2021.

-MarketWatch Automation

	

(END) Dow Jones Newswires

September 22, 2021 17:13 ET (21:13 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.